...
首页> 外文期刊>Genome Announcements >Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
【24h】

Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1

机译:耐多药临床分离结核分枝杆菌187.0的完整基因组序列,用于研究新药FS-1逆转药敏性的作用

获取原文
           

摘要

Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line anti-tuberculosis (TB) drugs under the influence of a new medicinal drug FS-1.
机译:给出了多药耐药临床分离株结核分枝杆菌 SCAID 187.0的完整基因组序列,其中包含几个耐药突变。该菌株在实验中用于研究基因组和种群变化,从而导致在新药FS-1的影响下对一线抗结核(TB)药物的敏感性恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号